Access cutting-edge bladder cancer treatment through this clinical trial at a research site in Little Rock. Study-provided care at no cost to qualified participants.
Access bladder cancer specialists in Little Rock at no cost
This study follows strict safety protocols and ethical guidelines
All study-related bladder cancer treatment provided free
This phase II trial studies how well gemcitabine hydrochloride and cisplatin work in treating participants with invasive bladder urothelial cancer. Drugs used in chemotherapy, such as gemcitabine hydrochloride and cisplatin, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading.
Sponsor: Alliance for Clinical Trials in Oncology
Check if you qualify for this bladder cancer clinical trial in Little Rock, AR
If you're searching for bladder cancer treatment options in Little Rock, AR, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Little Rock research site is actively enrolling participants for this clinical trial. You'll receive care from experienced bladder cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.